Virtus LifeSci Biotech Clinical Trials ETF (BBC)
- Previous Close
26.52 - Open
27.22 - Bid 27.61 x 1100
- Ask 27.67 x 800
- Day's Range
27.22 - 27.69 - 52 Week Range
16.88 - 31.99 - Volume
805 - Avg. Volume
4,017 - Net Assets 10.42M
- NAV 26.52
- PE Ratio (TTM) --
- Yield 0.32%
- YTD Daily Total Return 8.44%
- Beta (5Y Monthly) 0.98
- Expense Ratio (net) 0.79%
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Virtus
Fund Family
Health
Fund Category
10.42M
Net Assets
2014-12-16
Inception Date
Performance Overview: BBC
Trailing returns as of 5/31/2024. Category is Health.
People Also Watch
Holdings: BBC
Top 10 Holdings (22.60% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: BBC
Alibaba Earnings: More Positive Outlook Despite Mixed Results; Raising Fair Value Estimate by 2%
Alibaba is the world’s largest online and mobile commerce company as measured by gross merchandise volume. It operates China’s online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.
RatingPrice TargetLowering Anglo American's Fair Value Estimate by 10% After BHP Walks Away
Anglo American's mining portfolio spans many commodities and continents. Like fellow large diversified miners, Anglo has significant exposure to copper, iron ore and metallurgical coal, but it is unique among the global majors given its significant platinum group metals and diamonds output. The company accounts for about one third of the world’s platinum supply and around 30% of palladium supply. Anglo also owns 85% of De Beers, in most years the world's largest supplier and marketer of rough gem diamonds by value. Anglo also plans to move back into the crop nutrients business via its Woodsmith polyhalite project in the United Kingdom.
RatingPrice TargetNetflix Earnings: Fantastic Period Dampened by Likelihood of Growth Deceleration
Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
RatingPrice TargetRaising target price to $201.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target